Literature DB >> 30085245

Renal albumin excretion in healthy young adults and its association with mortality risk in the US population.

Jiehan Chong1, James Fotheringham1, Charles Tomson2, Timothy Ellam2.   

Abstract

BACKGROUND: Current classification systems do not specify a healthy normal range for urinary albumin excretion. Occult microvascular disease induced by a Western lifestyle may mean that normal values for apparently healthy adults exceed optimal levels defined by mortality risk.
METHODS: Using a national population sample [the US Third National Health and Nutrition Examination Survey (NHANES III) cohort; n = 11 887], the distributions of albumin:creatinine ratio (ACR) and fractional excretion of albumin (FEalb) were studied in healthy young adults [ages 20-40 years, without cardiovascular disease (CVD) or risk factors]. The threshold for mortality risk prediction in the whole adult population sample was then studied across ACR/FEalb categories corresponding to quartiles for healthy young adults.
RESULTS: ACR quartiles for healthy young adults were 2.7, 4.2 and 5.9 mg/g in men and 3.8, 6.2 and 9.8 mg/g in women. Increases in ACR below the medians for healthy young adults were not associated with increased mortality or with cardiovascular risk factors when tested in the whole adult population. Increases above this threshold were independently associated with mortality risk [hazard ratio 1.2 (95% confidence interval 1.1-1.4) and 1.8 (1.6-2.0) for Quartiles 3 and 4, respectively]. The prevalence of an optimal ACR below the mortality risk threshold was <25% in the setting of diabetes, hypertension, age >70 years or CVD. Using FEalb to define quartiles of albuminuria gave the same findings.
CONCLUSION: Based on mortality risk in the whole adult population, there is an optimal range of albumin excretion (ACR < 6 mg/g and 4 mg/g for women and men, respectively). However, only half of even apparently healthy young US adults fall within this range.
© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  CKD; albuminuria; population; survival

Year:  2020        PMID: 30085245     DOI: 10.1093/ndt/gfy242

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Larger nephron size, low nephron number, and nephrosclerosis on biopsy as predictors of kidney function after donating a kidney.

Authors:  Naim Issa; Lisa E Vaughan; Aleksandar Denic; Walter K Kremers; Harini A Chakkera; Walter D Park; Arthur J Matas; Sandra J Taler; Mark D Stegall; Joshua J Augustine; Andrew D Rule
Journal:  Am J Transplant       Date:  2019-02-01       Impact factor: 8.086

2.  Clinical, biochemical, and miRNA profile of subjects with positive screening of primary aldosteronism and nonclassic apparent mineralocorticoid excess.

Authors:  Alejandra Tapia-Castillo; Cristian A Carvajal; Jorge A Pérez; Carlos E Fardella
Journal:  Endocrine       Date:  2022-06-08       Impact factor: 3.925

3.  Microalbuminuria and its Prognostic Significance in Patients with Acute Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction.

Authors:  Ömer Doğan Alataş; Murat Biteker; Ahmet Demir; Birdal Yıldırım; Ethem Acar; Kemal Gökçek; Aysel Gökçek
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

Review 4.  Microalbuminuria and cardiorenal risk: old and new evidence in different populations.

Authors:  Diego Francisco Márquez; Gema Ruiz-Hurtado; Julian Segura; Luis Ruilope
Journal:  F1000Res       Date:  2019-09-19

Review 5.  Oxidized Albumin as a Mediator of Kidney Disease.

Authors:  Stefanny M Figueroa; Patricio Araos; Javier Reyes; Basile Gravez; Jonatan Barrera-Chimal; Cristián A Amador
Journal:  Antioxidants (Basel)       Date:  2021-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.